...
首页> 外文期刊>Human Pathology >Large cell calcifying Sertoli cell tumor: a clinicopathologic study of 1 malignant and 3 benign tumors using histomorphology, immunohistochemistry, ultrastructure, comparative genomic hybridization, and polymerase chain reaction analysis of the PRKAR1A gene.
【24h】

Large cell calcifying Sertoli cell tumor: a clinicopathologic study of 1 malignant and 3 benign tumors using histomorphology, immunohistochemistry, ultrastructure, comparative genomic hybridization, and polymerase chain reaction analysis of the PRKAR1A gene.

机译:大细胞钙化支持细胞瘤:使用PRKAR1A基因的组织形态学,免疫组化,超微结构,比较基因组杂交和聚合酶链反应分析对1例恶性和3例良性肿瘤进行临床病理研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Four cases of large cell calcifying Sertoli cell tumor, 3 benign and 1 malignant, with no clinical signs of Carney complex or Peutz-Jeghers syndrome are reported with results of histologic, immunohistochemical, ultrastructural, and comparative genomic hybridization studies. Analysis of PRKAR1A gene was performed on 2 cases. The age range of the patients was 19 to 54 years. The patient with a malignant large cell calcifying Sertoli cell tumor died of disease 4 years after surgery. Patients with benign tumors have had an uneventful follow-up for 1 and 3 years. All tumors were well circumscribed, unencapsulated, and composed of solid sheets, irregular cords, tubular structures, and nests in a fibrous and/or myxoid stroma with cellular atypia in the malignant case. All tumors showed diffuse immunoreactivity for inhibin, vimentin, calretinin, and S100 protein. Focal positivity for cytokeratin (AE1/AE3) was noticed in 1 case. Tumors were negative for CAM 5.2, Mic-2, Melan-A laminin, placental alkaline phosphatase, and alpha-fetoprotein. The proliferation index was 5% and 10% for 2 of the benign tumors and 30% for the malignant tumor. Comparative genomic hybridization was performed in 2 cases. There was no evidence of any major chromosomal changes. In one case, no PRKAR1A gene mutation was found. In the other case, a heterozygous shift mutation c.65_84dup was found, despite the absence of other clinical signs of Carney complex or Peutz-Jeghers syndrome. Although the combination of large cell calcifying Sertoli cell tumor and PRKAR1A mutation fulfills the criteria for establishing a diagnosis of Carney complex, the clinical relevance of finding a PRKAR1A gene mutation in a patient without any clinical signs of Carney complex or Peutz-Jeghers syndrome remains to be established.
机译:据组织学,免疫组化,超微结构和比较基因组杂交研究的结果,报告了四例大细胞钙化支持细胞肿瘤,3例良性和1例恶性,无Carney复合体或Peutz-Jeghers综合征的临床体征。分析2例PRKAR1A基因。患者的年龄范围是19至54岁。患有恶性大细胞钙化支持细胞肿瘤的患者在手术后4年死于疾病。患有良性肿瘤的患者随访了1年和3年。所有肿瘤均被很好地界定,未包囊,并且由实心片,不规则的绳索,管状结构和纤维状和/或粘液样基质中的巢组成,在恶性病例中具有细胞异型性。所有肿瘤对抑制素,波形蛋白,钙网蛋白和S100蛋白均表现出弥漫性免疫反应。在1例中发现细胞角蛋白(AE1 / AE3)的局灶性阳性。肿瘤对CAM 5.2,Mic-2,Melan-A层粘连蛋白,胎盘碱性磷酸酶和甲胎蛋白呈阴性。对于2个良性肿瘤,其增殖指数为5%和10%,对于恶性肿瘤,其增殖指数为30%。比较基因组杂交2例。没有证据表明任何重大的染色体变化。在一种情况下,未发现PRKAR1A基因突变。在另一种情况下,尽管不存在卡尼复合体或Peutz-Jeghers综合征的其他临床体征,但仍发现杂合移位突变c.65_84dup。尽管大细胞钙化支持细胞瘤和PRKAR1A突变的组合满足了诊断Carney复合体的标准,但是在没有任何Carney复合体或Peutz-Jeghers综合征临床症状的患者中发现PRKAR1A基因突变的临床意义仍然被建立。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号